DHL is broadening its airfreight cold chain network to accommodate the needs of the pharmaceutical industry.

DHL Group is expanding its airfreight cold chain network to enhance the secure transport of sensitive medical products, backed by a €2 billion investment in its health logistics division. This shift aims to reduce reliance on third-party airlines by launching a dedicated Boeing 777 service between Brussels and Cincinnati, facilitating a direct link between Europe and the U.S. pharmaceutical hub. The new network offers a reliable, compliant, and efficient logistics solution, improving temperature control and operational resilience against global challenges while lowering costs and environmental impact.